This site is intended for health professionals only

Home / News / Manufacturer recalls insulin pens over fears they may be ‘structurally compromised’

Manufacturer recalls insulin pens over fears they may be ‘structurally compromised’

24 Aug 2017

Manufacturer Novo Nordisk is recalling certain batches of NovoPen® Echo® and NovoPen® 5 over fears the insulin cartridge holder could crack, leading to under-delivery of insulin and hyperglycaemia.

Novo Nordisk said this component of the devices can be ‘structurally compromised’ if exposed to certain chemicals – including household cleaning products.

Patients with diabetes using the products from the affected batches should contact Novo Nordisk to replace the cartridge holder.

Details of the affected batches can be found here.

John Wilkinson, director of medical devices at the Medicines and Healthcare products Regulatory Agency (MRHA), said: ‘This is a company-led recall and we are supportive of the proactive approach being taken by Novo Nordisk.

‘It is important patients do not stop treatment without contacting their diabetes management team. We are asking people using a NovoPen® Echo® and/or NovoPen® 5 from one of the affected batches to contact Novo Nordisk to replace the cartridge holder as some could be damaged or subject to damage in the future.

We continue to encourage people to report any issues involving medical devices to the MHRA via our Yellow Card Scheme.’

Dan Howarth, head of care at the charity Diabetes UK, said: ‘Ensuring the correct level on insulin is vitally important in the management of diabetes; so it’s important that anyone affected by this recall contact Novo Nordisk to arrange for a replacement cartridge holder.

‘If they have any concerns about their level of insulin they should consult with their diabetes care team.’

Want news like this straight to your inbox?

Latest News

booster jab
Half of those eligible have received Covid booster jab
More than half of those eligible for a Covid booster jab in England have received...
Pharmacy must be better integrated into the NHS to support self-care, say health bodies
The pharmacy sector should be better integrated into the healthcare system in England in order to encourage...
Pharmacies should directly approach GPs and PCNs to recruit patients for hypertension service
Pharmacies have been encouraged by NHS England and Improvement (NHSE&I) to take a proactive role...